Mehr Lebenskraft - Mit Kerstin Hardt · Kerstin Hardt

#642 - "Das sind die wahren Gründe einer Krebserkrankung." Interview mit Experten Lothar Hirneise (1. Teil)

·33 min·2 clips

Lothar Hirneise explains why cancer mutations are not the cause, but a later consequence of the disease.

1. Mehr Lebenskraft episode 642 features Kerstin Hardt interviewing Lothar Hirneise, an independent cancer researcher who has spent 27 years investigating why certain people recover from cancer against medical expectations. 2. Lothar Hirneise is the author of 'Chemotherapy against Cancer' (Chemotherapie heilt Krebs und die Erde ist eine Scheibe) and board member of Krebs 21, a German association for non-university cancer therapies. 3. The episode's central argument is that conventional oncology has pursued the wrong model of cancer causation since Nixon's 1972 War on Cancer, and that stress and psychological state are the primary drivers of cancer development and recovery. 4. Hirneise explains that before the 1970s, approximately 90% of doctors worldwide understood cancer as a systemic disease affecting the whole organism, not a local DNA mutation. 5. He attributes the shift to Richard Nixon's War on Cancer declaration on December 23, 1972, which redirected massive research funding to the DNA mutation model despite only 10-20% of doctors initially supporting this view. 6. Hirneise uses the metaphor of 'setting the ladder on the wrong wall' to describe how the entire discipline committed to a model that he argues is demonstrably incorrect, making it psychologically impossible for professors to now reverse course. 7. He describes the DNA mutation argument as a logical error: mutations are observed after 30-40 cell divisions, meaning they are effects of cancer, not causes — something present at every stage was mistaken for the origin. 8. Chemotherapy originated from the observation of mustard gas (cyclophosphamide) casualties after a 1940s Italian ship explosion; American doctors noted bone marrow destruction and deliberately applied the poison to leukemia patients. 9. The therapy was extended from bone marrow diseases to all cancers in the 1960s-70s despite being designed only for fast-dividing cells — a problem because most epithelial tumors divide slowly. 10. Hirneise cites three studies showing chemotherapy's ineffectiveness with epithelial tumors: Ulrich Abel's meta-study at Heidelberg University (book later discontinued), Professor Hölzel's Munich study (reached the cover of Stern magazine), and an Australian study reporting a 2-3% success rate summary. 11. He argues chemotherapy is genuinely effective for only about 5% of cancers — leukemia, lymphoma, and testicular cancer — where cells divide rapidly. 12. For brain tumors, he cites studies showing a near-100% relapse rate after surgery, and for breast cancer radiation, he notes that 0.3 gray creates cancer cells in a lab from healthy cells while a standard treatment delivers 54 gray (approximately 160 times the cancer-causing dose). 13. Kerstin adds her own observation that even slim, athletic-looking patients in her seminars often have unresolved trauma and chronic stress as identifiable underlying factors. 14. Hirneise's central empirical claim: of thousands of terminal-stage cancer survivors he and American colleague Frank Wiebel have interviewed worldwide, not one attributed their recovery to conventional chemotherapy or treatment. 15. He argues the most important cancer therapy is the ability to be happy, because only during parasympathetic (stress-free) states can the body's 30 trillion cells perform the repair processes needed to correct cancer. 16. The mechanism proposed is that chronic adrenalin and cortisol from unresolved stress and trauma flood the body, preventing the normal apoptosis (programmed cell death) that removes damaged cells. 17. Cancer cells, he argues, are cells that have switched to anaerobic metabolism (living without oxygen) in response to chronic stress, mirroring a survival program present in virtually all cells from evolutionary history. 18. The episode is a fairly technical interview with a conversational but dense format, mixing historical narrative with biochemical explanation. 19. People dealing with a cancer diagnosis or caring for someone with cancer who want perspective outside mainstream oncology, and German-speaking listeners with interest in alternative health frameworks, will find this episode most relevant. 20. Listeners expecting peer-reviewed clinical evidence for the claims made, or who are currently undergoing conventional treatment and want to avoid contradictory information, should approach this content with caution.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Mehr Lebenskraft - Mit Kerstin Hardt